Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 9, 2011

View Archived Issues

Cancer/testis family antigen described as independent predictor of prostate cancer recurrence

HDAd-mediated apolipoprotein A-I expression protects against atherosclerosis in vivo

Alere to make cash offer for Axis-Shield

Unigene and GSK enter further agreement for oral PTH analogue

FDA accepts NDA filing for BDP Nasal HFA

Novel lysophospholipid S1P1 receptor agonists presented by Sanofi

Botox receives positive opinion from Irish Medicines Board

Chelsea Therapeutics reaches target enrollment in phase II trial in fibromyalgia

French company presents novel agents for Parkinson's disease

Zafgen discloses new methionine aminopeptidase 2 inhibitors

Enrollment commences in phase I/II trial of OPB-31121

New hedgehog signaling inhibitors prepared at Selexagen

MGA-271 enters phase I trial in refractory cancer

Enrollment begins in first-in-human trial of SAR-125844

New androgen receptor antagonists claimed

Oasmia and Orion terminate agreement for Paclical in the Nordic region

ESMO and Thomson Reuters launch OncologyPRO portal

HUYA and SJTU School of Pharmacy King's Lab join forces

NeurogesX raises funds to support product development

SYGNIS completes recruitment in AXIS 2 study

Gilead to acquire clinical biologics manufacturing facility from Genentech

Phase III study of tivantinib/erlotinib combination begins in NSCLC

RNAi screen leads to identification of new target and agent for treatment of AML

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...